Top Ten Equity Holdings & Exposures

RNS Number : 7828K
Polar Cap Gbl Healthcare Growth&IT
04 January 2016
 



 

4th January 2016

 

Polar Capital Global Healthcare Growth and Income Trust plc (the "Company")

 

Top Ten Equity Holdings and Sector and Geographic Exposures as at 31- Dec -15 and full Portfolio listing as at 30-Nov-15 available from company's website

 

Polar Capital Global Healthcare Growth and Income Trust plc is pleased to announce that as at 31th December 2015 the top ten equity holdings and the sector and geographic breakdown were as follows:

 

Top 10 Holdings         

%

Johnson & Johnson

7.8%

AstraZeneca

7.5%

Eli Lilly & Co

7.3%

Roche

5.5%

Novartis

5.3%

Pfizer

4.9%

Sanofi

3.9%

Astellas Pharma

3.7%

Merck & Co

3.6%

Bristol Myers Squibb

3.4%

Total

53.0%

 

 

 

Sector Exposure

%

Pharmaceuticals

63.2%

Healthcare Equipment

6.8%

Biotechnology

6.2%

Healthcare REITs

4.5%

Healthcare Facilities

4.2%

Healthcare Services

2.1%

Managed Healthcare

1.6%

Healthcare Distributors

1.5%

Healthcare Supplies

0.7%

Life & Health Insurance

0.4%

Life Sciences Tools & Services

0.1%

Diversified Real Estate Activities

0.0%

Cash

8.7%

Total

100.0%



 

 

 

 

 

 

 

 

Geographic Exposure

%

United States

43.1%

United Kingdom

12.9%

Switzerland

11.6%

Japan

6.1%

France

4.0%

Israel

3.3%

Australia

2.2%

Germany

1.9%

Canada

1.8%

Ireland

1.7%

Italy

1.0%

India

0.8%

Belgium

0.5%

Norway

0.4%

Cash

8.7%

Total

100%



 

 

The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager.  www.Polarcapitalhealthcaretrust.com 

 

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUQZLFBQFFZBBL
UK 100

Latest directors dealings